PROCEPT BioRobotics Corporation
PRCT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4 | $2 | $2 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $4 | $2 | $2 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 64.8% | 81.6% | 117.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 61.1% | 52.2% | 49.4% | 46% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -36.5% | -72% | -105.5% | -147.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -40.7% | -77.8% | -116.2% | -173.6% |
| EPS Diluted | -1.75 | -2.24 | -1.96 | -3.63 |
| % Growth | 21.9% | -14.3% | 46% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |